Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Filings indexed 537 across all filing types
Latest filing 2023-07-03 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
关于减少注册资本通知债权人的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Beijing Kangle Weishi Biotechnology Co., Ltd. regarding a reduction in registered capital due to the repurchase and cancellation of restricted stock related to an equity incentive plan. It notifies creditors about the capital reduction and provides details on how creditors can submit claims within a specified period. The document references board and shareholder meetings approving the capital reduction and complies with relevant laws and stock exchange rules. The content is a formal notice to creditors about the capital reduction and related procedures, not a financial report or detailed financial statements. It is also relatively short (1317 characters) and serves as an official announcement rather than a report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-07-03 Chinese
北京观韬中茂律师事务所关于北京康乐卫士生物技术股份有限公司2023年第七次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and procedural compliance of a company's 2023 seventh extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or performance data but focuses on the legal validation of the shareholders' meeting process and resolutions. This type of document is not an annual report, earnings release, or management report but rather a legal opinion related to a shareholders' meeting. It is not a simple announcement but a formal legal opinion letter. Given the content and purpose, the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it includes detailed voting results and confirms the legality of the voting process and outcomes at a shareholders' meeting.
2023-06-29 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Beijing Health Guard Biotechnology Inc. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance matters. It is a comprehensive governance document that outlines the internal rules and regulations of the company rather than financial results, audit opinions, or meeting announcements. There is no indication that this is an announcement or a report publication notice. The content aligns with the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2023-06-29 Chinese
2023年第七次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 7th Extraordinary General Meeting (临时股东大会) of Beijing Kangle Weishi Biotechnology Co., Ltd. It includes information about the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder voting outcomes and corporate governance decisions such as share repurchase and amendments to the company charter. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2408 characters, which is sufficient to contain detailed voting results rather than just a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2023-06-29 Chinese
关于昆明分公司完成工商登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration for a new branch (昆明分公司) of the company 北京康乐卫士生物技术股份有限公司. It includes details about the establishment, registration date, and business license information. There is no financial data, no mention of financial results, no discussion of management changes, no voting results, and no regulatory certifications. The document is a formal announcement of a corporate event related to business registration, which does not fit into financial reports or management changes categories. It is a regulatory announcement about company structure and registration, best classified under Regulatory Filings (RNS). The document length is short (748 characters), and it is not a report publication announcement or certification letter, so RNS is appropriate.
2023-06-29 Chinese
董事长、董事及董事会秘书辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the chairman, directors, and board secretary of the company. It details the resignation dates, shareholdings of the resigning members, reasons for resignation, and the impact on the company. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content clearly relates to changes in the company's board and senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification with high confidence.
2023-06-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.